Acute myocardial infarction (AMI) remains the leading cause of death in developed countries. Although reperfusion of coronary arteries reduces mortality, it is associated with tissue injury. Endothelial P-selectin-mediated infiltration of neutrophils plays a key role in reperfusion injury. However, the mechanism of the P-selectin induction is not known. Here we show that infarct size after ischemia/reperfusion was significantly smaller in mice lacking guanylyl cyclase-A (GC-A), a natriuretic peptide receptor. The decrease was accompanied by decreases in neutrophil infiltration in coronary endothelial P-selectin expression. Pretreatment with HS-142-1, a GC-A antagonist, also decreased infarct size and P-selectin induction in wild-type mice. In cultured endothelial cells, activation of GC-A augmented H 2 O 2 -induced P-selectin expression. Furthermore, ischemia/reperfusion-induced activation of NF-κB, a transcription factor that is known to promote P-selectin expression, is suppressed in GC-A-deficient mice. These results suggest that inhibition of GC-A alleviates ischemia/reperfusion injury through suppression of NF-κB-mediated P-selectin induction. This novel, GC-A-mediated mechanism of ischemia/reperfusion injury may provide the basis for applying GC-A blockade in the clinical treatment of reperfusion injury. uretic peptide signaling on the size of myocardial infarcts evoked by protocols of ischemia and reperfusion.
Introduction
Although acute myocardial infarction (AMI) remains the leading cause of death in developed countries, advances in the treatment of ischemic heart diseases have led to a decrease in mortality over the past three decades. For instance, reperfusion of coronary arteries with thrombolytic agents (1) or angioplasty (2-4) markedly reduces mortality and improves left ventricular function in AMI. Nonetheless, reperfusion after even brief periods of ischemia is associated with pathological alterations that represent either an acceleration of processes initiated during ischemia, per se, or new changes initiated during the reperfusion (5) (6) (7) .
Ischemia/reperfusion prompts a release of reactive oxygen species (8) , cytokines (9, 10) , and other proinflammatory mediators that activate both neutrophils and coronary vascular endothelium. Such activation promotes the expression of adhesion molecules on both neutrophils and endothelium (11, 12) , which recruits the former to the surface of the latter and initiates a specific cascade of cell-cell interactions, leading first to adherence of neutrophils to the endothelium and then to transendothelial migration and direct interaction with myocytes (13, 14) . This reperfusion injury shares many characteristics with inflammatory responses in which neutrophils feature prominently.
Atrial and brain natriuretic peptides (ANP and BNP, respectively) are hormones secreted from the heart that possess potent diuretic, natriuretic, and vasorelaxant activities. They exert their effects through activation of the guanylyl cyclase-A (GC-A) receptor, which leads to an increase in the intracellular second messenger, cGMP (15) . We and others have shown previously that cardiac natriuretic peptide systems are rapidly activated (16) (17) (18) (19) (20) (21) , and plasma BNP concentrations are markedly elevated (22) after AMI. Although expression of the GC-A gene is known to occur in the ventricle (23, 24) , virtually nothing is known about the intracardiac functions of natriuretic peptides in AMI.
We therefore used genetically engineered, GC-A-deficient mice and HS-142-1, a nonpeptide GC-A antagonist (25) , to investigate the effects blocking endogenous natri-(A 2 × W 2 ) + (A 3 × W 3 ) + (A 4 × W 4 ) + (A 5 × W 5 )], where A is the area of infarct for the slice denoted by the subscript and W is the weight of the respective section. The weight of the AAR was calculated in similar fashion. Infarct was expressed as a percentage of the AAR and LV. Areas were determined independently by three observers blinded to the treatment protocol.
Histology. To determine the numbers of infiltrating polymorphonuclear neutrophils (PMNs), slices treated as described above were fixed in 4% paraformaldehyde at 4°C, embedded in paraffin, cut into 4-µm sections, and transferred to silicon-coated slides. The tissue sections were then stained with hematoxylin and eosin (H&E) or Giemsa. The numbers of PMNs per highpower microscope field (×400) were independently counted by two observers blinded to the treatment protocol. Average numbers of PMNs were obtained by randomly counting more than ten fields.
Myeloperoxidase activity. Neutrophil emigration was assessed by measuring myeloperoxidase (MPO) activity (27) . Each heart was divided into infarct and noninfarct areas, after which the respective areas were homogenized and sonicated in 50 mmol/l potassium phosphate buffer, pH 6, containing 0.5% hexadecyltrimethylammonium bromide (HTAB). The mixture was then centrifuged at 12,500 g for 30 minutes at 4°C. The supernatant was collected into another tube and mixed with reaction buffer (0.167 mg/ml of o-dianisidine dihydrochloride and 0.0005% H 2 O 2 in 50 mmol/l phosphate buffer, pH 6). Absorbance of these mixtures at 460 nm was measured using spectrophotometer, with the rate of change in absorbance being related to MPO activity. One unit of MPO activity was defined as that hydrolyzing 1 mmol of peroxidase per minute at 25°C.
Immunohistochemistry. Sections obtained as described above were treated with 3% H 2 O 2 to block endogenous peroxidase and then incubated for 1 hour at room temperature with rabbit polyclonal anti-P-selectin Ab (PharMingen, San Diego, California, USA) at a dilution of 1:200. The sections were then incubated with biotinylated rabbit IgG (DAKO, Tokyo, Japan), and Abbinding sites were visualized as an avidin-biotin peroxidase complex using 3-amino-9-ethyl carbazole (AEC).
Western blot analysis. Left ventricles were homogenized using a polytron homogenizer and sonicated in lysis buffer (20 mmol/l Tris, 150 mmol/l NaCl, 1 mmol/l EDTA, 1 mmol/l EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mmol/l β-glycerolphosphate, 1 mmol/l Na 3 VO 4 , 1 µg/ml leupeptin, and 1 mmol/l PMSF). The resultant mixture was centrifuged at 25,000 g for 5 minutes, the supernatant collected, and the total protein concentration was determined using a standard protein assay (Bio-Rad Laboratories Inc., Hercules, California, USA). Samples containing approximately 100 µg of protein were then subjected to 7.5% SDS-PAGE in TrisTricine SDS buffer, after which the gels were transferred electrically to Sequi-Blot PVDF membranes (Bio-Rad Laboratories Inc.). Membranes were then blocked for 1 hour at room temperature in Tris-buffered saline con-taining 1% Tween 20 (TBS-T) and 5% nonfat milk. They were then incubated for 1 hour with gentle agitation at room temperature with rabbit polyclonal anti-P-selectin Ab in TBS-T (1:1000 dilution), washed three times with TBS-T, and incubated with horseradish peroxidase-conjugated (HRP-conjugated) anti-rabbit secondary Ab (DAKO) for 1 hour at room temperature. After four to five washes with TBS-T, the proteins were visualized using Renaissance enhanced chemiluminescent reagents (NEN Life Science Products Inc., Boston, Massachusetts, USA), and the membranes were autoradiographed.
Isolation of nuclear extracts. Nuclear extracts were prepared from frozen myocardial tissue as described previously (28, 29) . Tissue samples were rinsed three times with ice-cold Ca 2+ -free and Mg 2+ -free PBS, and then homogenized in 3 ml of ice-cold buffer A (10 mmol/l HEPES, pH 7.9, 1.5 mmol/l MgCl 2 , 10 mmol/l KCl, 1 mmol/l DTT, and 1 mmol/l PMSF) using a Dounce homogenizer. Human umbilical vein endothelial cells (HUVECs) were detached with 0.5% EDTA, rinsed twice with PBS, and incubated with buffer A in a centrifuge tube. The homogenate was transferred to a centrifuge tube. After a 10-minute incubation on ice, the homogenate was centrifuged at 850 g for 10 minutes at 4°C. The cell pellet was suspended in ice-cold buffer B (0.1% Triton X-100 in buffer A), incubated on ice for 10 minutes, and then centrifuged again as above. The resultant nuclear pellet was rinsed once with buffer A, resuspended in buffer C (20 mmol/l HEPES, pH 7.9, 25% glycerol vol./vol., 0.42 mol/l NaCl, 1.5 mmol/l MgCl 2 , 0.2 mmol/l EDTA, 0.5 mmol/l DTT, and 1 mmol/l PMSF), and incubated on ice for 30 minutes. Nuclear proteins were obtained by centrifugation at 20,000 g for 15 minutes at 4°C. The protein concentrations were determined as described above.
Electrophoretic mobility shift assay. A double-stranded oligonucleotide containing the consensus-binding sites for NF-κB (5′-GATCGAGGGGACTTTCCCTAGC-3′) was end-labeled with [γ-32 P]ATP (Amersham Pharmacia Biotech, Piscataway, New Jersey, USA) using T4 polynucleotide kinase. The reaction mixture was then incubated with 10 µg of nuclear protein for 30 minutes, loaded onto 5% polyacrylamide gel, and electrophoresed at 250 V in 0.5× Tris-borate EDTA buffer. The gels were dried using a Gel-Drier and radiographed, after which the binding bands were semiquantified by scanning densitometry.
Competition experiments were performed to assess the specificity of NF-κB-binding activity determined by electrophoretic mobility shift assay (EMSA). Nuclear extracts were incubated with unlabeled double-stranded NF-κB oligonucleotides for 5 minutes and then with labeled NF-κB oligonucleotides for an additional 30 minutes. Ab supershift assays were then performed to confirm that apparently bound NF-κB contained the p50 subunit. The labeled reaction mixture was incubated for 30 minutes; then 2 µg of anti-p50 Ab was added. After incubation for an additional 2 hours at 4°C, samples were run on polyacrylamide gels.
Radioimmunoassay. Ventricular ANP and BNP concentrations were measured by our specific radioimmunoassays (RIAs) reported previously (30) . Tissue cGMP concentration was measured by Yamasa Cyclic GMP Assay Kit (Yamasa Co., Chiba, Japan).
Cell cultures. HUVECs and EBM-2 culture medium were purchased from Sanko Jyunyaku (Tokyo, Japan). The cells were plated into 75-cm 2 culture dishes (Becton Dickinson and Co., Franklin Lakes, New Jersey, USA) and maintained in EBM-2 medium supplemented with 2% FBS under a humidified atmosphere of 5% CO 2 /95% air at 37°C. The medium was renewed every 2 days. Subcultures were obtained by treating the HUVEC cultures with 0.25% trypsin/0.01% EDTA at 37°C for 5 minutes. Subconfluent HUVECs from passages five through eight were used in all experiments.
Cell culture protocol. To examine the effects of ANP and GC-A, HUVECs were exposed for 1 hour or 6 hours to the indicated doses of H 2 O 2 alone or in combination with ANP (10 -8 M or 10 -6 M), in the presence or the absence of 100 µg/ml HS. ELISA. To assess cell surface expression of P-selectin, HUVECs cultured in 96-well plates were incubated for 1 hour with the indicated medium, washed twice with PBS, and fixed for 15 minutes with 1% paraformaldehyde. To determine total P-selectin expression, the cells were incubated for 6 hours with the indicated medium and fixed in ethanol to permeabilize their membranes (31, 32) , washed twice with PBS, fixed for an additional 30 minutes in ethanol, and incubated for 1 hour in a 2% BSA-HBSS solution. The cells were then incubated for 2 hours with mouse monoclonal anti-human P-selectin Ab (1:500 dilution; DAKO), followed by incubation for 1 hour with peroxidase-conjugated anti-mouse secondary Ab (1:2000 dilution; DAKO), and then for 30 minutes with 100 µl/well of substrate chromogen (3,3′,5,5′-tetramethylbenzidine). All incubations were performed at room temperature. Chromophore development was determined by measuring OD at 650 nm with a Spectramax microplate reader. Background absorbance was determined using cells incubated without primary Ab's.
Detection of intracellular peroxides with ANP. HUVECs were incubated with normal medium, 10 -8 M ANP, and 10 -6 M ANP for 1 hour. As a control, HUVECs were incubated with 100 µM H 2 O 2 . HUVECs were detached from the culture plate with 0.5% EDTA. To determine intracellular peroxides, endothelial cells were incubated with 5-(and-6) carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H 2 DCFDA) (Molecular Probes Inc., Eugene, Oregon, USA). Approximately 10,000 cells were analyzed by flow cytometry to determine the oxidation of carboxy-H 2 DCFDA that occurs during oxidative stress, according to the previous report by Bass et al. (33) .
Cell viability. Mitochondrial respiration was assessed as a function of the mitochondria-dependent reduction of WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) to formazan. Cells plated in 96-well plates were incubated for 1 hour at 37°C with WST-8 (0.5 mmol/l). The extent of the reduction of WST-8 to formazan was quantified by measuring OD at 450 nm.
Statistical analyses. All values are expressed as means ± SEM. Statistical analysis of the data was performed by Student's t test. ANOVA with post hoc Duncan tests were used to determine the significance of differences in multiple comparisons. P values less than 0.05 were considered significant.
Results

Upregulation of ventricular ANP and BNP concentration and GC-A activity during myocardial ischemia/reperfusion in mice.
We measured tissue levels of ANP and BNP in the ventricle after ischemia-reperfusion by RIA. As shown in Table 1 , before ischemia/reperfusion the levels of ventricular ANP and BNP were 12.3 ± 2.7 ng/g and 38.9 ± 5.8 ng/g, respectively, which are about 100-fold higher than those of circulating ANP and BNP in mice. In mice treated with 30 minutes of ischemia followed by 6 hours of reperfusion, ventricular ANP and BNP levels were approximately three times higher than those in sham-operated mice. The ventricular BNP level continued to increase until 2 days after reperfusion, while ventricular ANP level tended to decrease slightly. Next, to examine whether ANP and BNP act on in the ventricle, we measured ventricular cGMP concentration during ischemia/ reperfusion in mice. In 2 days of reperfusion, ventricular cGMP levels were elevated significantly compared with those in sham-operated mice (13.3 ± 0.9 pmol/g in operated mice and 9.7 ± 0.9 pmol/g in
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The sham-operated mice; P < 0.05), indicating GC-A is activated during ischemia/reperfusion.
Decreased myocardial infarct size in GC-A -/-mice. The hearts of GC-A +/+
and GC-A -/-mice were subjected to ischemia/reperfusion. Just before the excision, hearts were perfused with Evans blue dye, sectioned, and incubated in 1.5% TTC as described in Methods. Photographs of representative ventricular sections from wild-type and GC-A -/-mice are shown in Figure 1a . Figure 1b illustrates a scheme showing the infarct area, AAR, and nonischemic area to assist in our understanding. The blue-stained tissue was defined as being perfused, the rest of the section was defined as AAR, and regions within the AAR that failed to exhibit brick-red staining were considered to be infarcts. AAR/LV ratios were not significantly different in the two genotypes (GC-A +/+ , 64.5 ± 7.2%; GC-A -/-, 63.2 ± 4.2%) (Figure 1c ), indicating that there was no genotypedependent difference in the extent of AAR produced by complete occlusion of the LAD and indicating that ligation site is the same in both groups. On the other hand, infarct/AAR was significantly smaller in GC-A -/-mice after 2 days of reperfusion (GC-A +/+ , 58.2 ± 5.2%; GC-A -/-, 44.6 ± 3.7%; P < 0.05) (Figure 1d ). Infarct/LV was also significantly smaller in GC-A -/-mice after 2 days of reperfusion (GC-A +/+ , 37.5 ± 3.4%; GC-A -/-, 28.2 ± 1.6%; P < 0.05) (Figure 1e ), demonstrating that the amount of myocardial tissue salvaged during reperfusion was larger in the absence of endogenous GC-A.
Decreased PMN infiltration number in GC-A -/-mice. One of the hallmarks of reperfusion injury is the accumulation of PMNs within the injured tissue (34) . In fact, interventions aimed at inhibiting PMN accumulation have been shown to exert cardioprotective effects in various experimental models. And in the present study, comparison of Figure 2 Decreased MPO activity in GC-A -/-mice. To further quantify the extent of PMN infiltration, we measured the activity of cardiac MPO, an enzyme specific to activated neutrophils. This method is commonly used to assess neutrophil accumulation and has been validated previously in cardiac tissue (27) . When myocardial MPO activity was measured in infarcted and noninfarcted tissues after 6 hours or 2 days of reperfusion, we found that the activity time dependently increased within the infarcted areas of both GC-A -/-and wild-type mice (GC-A +/+ , 0.46 ± 0.08 U/100 mg tissue; GC-A -/-, 0.31 ± 0.06 U/100 mg tissue after 6 hours of reperfusion; GC-A +/+ , 1.68 ± 0.03 U/100 mg tissue; GC-A -/-, 1.17 ± 0.03 U/100 mg tissue after 2 days of reperfusion) but that it was significantly lower in the GC-A-deficient mice at either time point (Figure 2f) . Within noninfarct areas, MPO activity was very low in both genotypes.
Decreased P-selectin expression in GC-A -/-mice. Endothelial cell surface expression of P-selectin (CD62), an integral membrane protein rapidly translocated to the plasma membrane during exocytosis of the Weibel-Palade bodies, promotes the binding and "rolling" of neutrophils, which precedes their migration into sites of inflammation (35) (36) (37) (38) (39) (40) (41) . To investigate the mechanism responsible for the reduced PMN infiltration in GC-A-deficient mice, we examined P-selectin expression after ischemia/reperfusion. Immunohistochemical analysis revealed that after 2 days of reperfusion, P-selectin was expressed in coronary microvascular endothelial cells in perinecrotic areas of both wild-type (Figure 3 , a, c, and e) and GC-A -/- (Figure 3, b, d , and f) mice, although the latter were labeled to a lesser degree. In contrast, P-selectin expression was barely detectable in sham-operated hearts. Western blot analysis, moreover, confirmed the significant (P < 0.01) declines in P-selectin expression in GC-A -/-mice after either 6 hours of reperfusion (GC-A +/+ , 3.11 ± 0.26 arbitrary units; GC-A -/-, 1.83 ± 0.08 arbitrary units; P < 0.01) or 2 days of reperfusion (GC-A +/+ , 5.65 ± 0.40 arbitrary units; GC-A -/-, 3.64 ± 0.53 arbitrary units; P < 0.01) (Figures 3, g and h) . Thus, the reduced PMN accumulation during ischemia/reperfusion in GC-A-deficient mice is likely due, at least in part, to suppressed expression of Pselectin in coronary endothelial cells.
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The Reduced NF-κB activity in GC-A -/-mice. NF-κB is a transcription factor that, by regulating the gene expression of multiple cytokines, chemokines, cell adhesion molecules, growth factors, and immunoreceptors, plays a critical role in immune and inflammatory reactions (42, 43) .
The P-selectin gene, which contains a functional NF-κB-binding site, is required for its induction in endothelial cells (44) . We therefore assessed NF-κB activation using EMSA with a NF-κB binding site-specific probe and nuclear proteins isolated from myocardial tissues of GC-A -/-and GC-A +/+ mice. No activation of NF-κB was detected in sham-operated mice of either genotype (Figure 4b, lanes 1 and 2, respectively) . In contrast, incubation with nuclear extracts from wild-type mice after 6 hours of reperfusion yielded a clearly detectable band (Figure 4b, lane 3) , the identity of which was confirmed by competition and supershift analyses with a specific Ab against the NF-κB p50 subunit (Figure 4a ). NF-κB activity was increased after 6 hours of reperfusion in wild-type mice (Figure 4b (Figure 4c ), which implies that GC-A might play a distinctive role in modulating ischemia/reperfusion injuries through inhibition of NF-κB activation. IκBα was phosphorylated in GC-A +/+ mice, whereas it is not phosphorylated in GC-A -/-mice after 6 hours of reperfusion. Phosphorylation of IκBα in GC-A +/+ mice and GC-A -/-mice after 2 days of reperfusion were upregulated to the same level. However, there was no significant change in IκBα protein level in GC-A -/-mice and GC-A +/+ mice after both 6 hours and 2 days of reperfusion ( Figure 4, d-g ).
Decreased myocardial infarct size, PMN infiltration, and P-selectin expression in mice treated with HS. To rule out that these effects were restricted within GC-A -/-mice, we next examined the effects of HS. Blockade of GC-A by intravenous injection of HS (3 mg/kg) was initially confirmed by the evoked decline in basal plasma cGMP levels (11.5 ± 1.7 pmol/ml in saline vs. 7.4 ± 0.6 pmol/ml in HS; P < 0.05). Whereas AAR/LV in both groups did not change (saline, 57.9 ± 3.0%; HS, 57.3 ± 7.2%) (Figure 5a ) after 2 days of reperfusion, injection of HS 30 minutes before coronary occlusion significantly reduced infarct/AAR ratio (saline, 56.5 ± 2.3%; HS, 38.7 ± 3.3%; P < 0.05) (Figure 5b ) and infarct/LV ratio (saline, 32.7 ± 2.1%; HS, 22.2 ± 2.5%; P < 0.05) (Figure 5c ), decreased the number of infiltrating PMNs after 2 days of reperfusion (saline, 17 ± 7 PMNs per high-powered field;, HS, 4 ± 1 PMNs per high-powered field; P < 0.01) (Figure 5d) , and decreased the MPO activity after 6 hours of reperfusion (saline, 0.42 ± 0.16 U/100 mg tissue; HS, 0.12 ± 0.08 U/100 mg tissue; P < 0.01) (Figure 5e ). Western blot analysis revealed that HS reduced the level of cardiac P-selectin expression seen after 6 hours of reperfusion (saline, 39.6 ± 10.4 arbitrary unit; HS, 8.9 ± 2.8 arbitrary unit; P < 0.01) ( Figure 5 , f and g), and there was a corresponding decline in the immunolabeling of Pselectin in coronary endothelial cells (data not shown). These findings further support the notion that blockade of endogenous natriuretic peptides decreases myocardial PMN infiltration after ischemia/reperfusion by inhibiting expression of P-selectin on endothelial cells.
Induction of P-selectin expression in HUVECs by ANP.
The aforementioned findings led us to hypothesize that ANP directly influences endothelial P-selectin expression during ischemia/reperfusion. To test this hypothesis, we assessed the effect of ANP on P-selectin expression in cultured HUVECs in the presence or absence of H 2 O 2 , a toxic by-product of respiration. Although we found only minimal immunolabeling of P-selectin (stained red) under basal conditions (Figure 6a ), several cells were labeled in the presence of 100 µM H 2 O 2 (Figure 6b ), indicating that exposure to H 2 O 2 induced expression of Pselectin. When incubated with H 2 O 2 plus 10 -6 M ANP, more cells were labeled and to a stronger degree than with H 2 O 2 alone (Figure 6c) , while exposure to H 2 O 2 , ANP, and 100 µg/ml HS resulted in cells being labeled to the same degree seen with H 2 O 2 alone (Figure 6d) .
Using a specific ELISA, we examined translocation of P-selectin to cell surface and total P-selectin expression of HUVECs. Treating cells for 1 hour with ANP alone dose dependently increased cell surface expression of P-selectin (saline, 1 ± 0.13; ANP 10 -8 M, 2.34 ± 0.41; ANP 10 -6 M, 3.64 ± 0.23 arbitrary units) (data not shown), and 100 µM H 2 O 2 alone for 1 hour increased cell surface P-selectin expression, as well. Cell surface expression of P-selectin in the presence of ANP was further increased by addition of 100 µM H 2 O 2 , which was suppressed by pretreatment with 100 µg/ml HS ( Figure  6e ). Incubating cells with ANP for 6 hours in the presence of 100 µM H 2 O 2 increased total expression of Pselectin, effects of which again were abolished by prior addition of HS (Figure 6f) .
Finally, cell viability assays, in which mitochondrial respiration was assessed as a function of the mitochondriadependent reduction of WST-8 to formazan, revealed that H 2 O 2 , ANP, and HS, either alone or in combination, had no effect on endothelial cell viability (data not shown). Thus, ANP appears to directly increase both cell surface and total expression of P-selectin protein in endothelial cells under oxidative stress.
NF-κB activation by ANP and/or H 2 O 2 in HUVECs.
We showed that NF-κB was activated in an ischemia/reperfusion model of wild-type mice, while it was not activated in GC-A -/-mice. Next, we examined NF-κB activation in HUVECs, which were treated with ANP in the presence of H 2 O 2 . As shown in Figure 7 , a and b, 10 -6 M ANP alone did not activate NF-κB in HUVECs. Modest activation of NF-κB was observed in H 2 O 2 -treated HUVECs in a good agreement with the previous report (45) . Surprisingly, ANP greatly augmented H 2 O 2 -induced NF-κB activation in HUVECs. These effects were abolished with HS ( Figure 7, a and b) . These results strongly suggest that, under oxidative condition as in ischemia/reperfusion, ANP could activate NF-κB in vascular endothelial cells. To further examine the mechanism for NF-κB activation, we performed Western blot analysis using specific Ab for phosphorylated IκBα and Ab for total IκB. As shown in Figure 7 , c and e, 10 -6 M ANP alone did not phosphorylate IκBα, but H 2 O 2 phosphorylated it. When ANP was added in combination with H 2 O 2 , IκBα was phosphorylated more compared with that by H 2 O 2 alone. However, incubation of cells with ANP in the presence of H 2 O 2 did not affect degradation of IκBα ( Figure 7, d and f) .
Incubation with ANP did not affect reactive oxygen species production in HUVECs. To investigate if ANP directly produces reactive oxygen species, we examined intracellular peroxides in HUVECs treated or not treated with ANP. The flow cytometric data shows the occurrence of oxidative stress in HUVECs exposed to hydrogen peroxide. In contrast, exposure of cells to 10 -6 M ANP did not affect carboxy-H 2 DCFDA oxidation, indicating that ANP does not directly induce oxidative stress in endothelial cells (data not shown).
Discussion
In the present study, we investigated the significance of the natriuretic peptide receptor, GC-A, during myocardial ischemia/reperfusion using genetically engineered GC-A-null mice. Surprisingly, myocardial infarct size after 2 days of reperfusion was approximately 20% smaller in GC-A-deficient mice than in wild-type mice.
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The Infarct size was also smaller in wild-type mice pretreated with HS, a nonpeptide GC-A antagonist. This reduction in infarct size was accompanied by corresponding declines in PMN infiltration, coronary endothelial cell expression of P-selectin, and activation of NF-κB. In addition, ANP directly induced upregulation of Pselectin expression in the presence or absence of H 2 O 2 , and ANP modulated H 2 O 2 -induced NF-κB activation in endothelial cells, the effects of which were abolished by pretreating cells with HS. Recent studies have shown that myocardial ischemia/ reperfusion injury could be suppressed by preventing PMN accumulation by inhibition of P-selectin, L-selectin, ICAM-1, or CD18, which are leukocyte adhesion receptors or cell adhesion molecules. For example, the sizes of myocardial infarcts elicited by ischemia/reperfusion were diminished in P-selectin-deficient, ICAM-1-deficient, or CD18-deficient mice (46, 47) . In addition, ischemia/ reperfusion-induced PMN infiltration and myocardial infarct size were both diminished in dogs treated with a monoclonal anti-P-selectin Ab (48) , and myocardial ischemia/reperfusion injuries were reduced by monoclonal Ab's directed against leukocyte adhesion receptor or cell adhesion molecules (49) (50) (51) . It thus appears that suppression of cell adhesion molecules or leukocyte adhesion receptors reduces ischemia/reperfusion injury and infarct size during the acute phase of myocardial ischemia/reperfusion. These reports are consistent with our present finding that GC-A inhibition and reduced expression of P-selectin were accompanied by decreases in myocardial PMN infiltration and infarct size.
To investigate the mechanism responsible for the attenuated expression of P-selectin in GC-A-deficient mice, NF-κB activation, which is known to promote P-selectin gene expression (52) , was assessed. In endothelial cells, NF-κB exists as a heterodimer made up of subunits designated p50 and p65 and is localized to the cytoplasm in the inactive form. Once activated by phosphorylation of IκB, an inhibitory protein, NF-κB is translocated to the nucleus, where it initiates transcription of a variety proinflammatory genes, including P-selectin (53) . We found that NF-κB activation was suppressed after 6 hours of reperfusion in GC-A-deficient mice, suggesting that decreases in P-selectin expression, in the number of infiltrating PMNs, and in myocardial infarct size could be at least partly due to the inhibition of ischemia/reperfusion-induced NF-κB activation in GC-A-deficient hearts. As shown in Figure 4 , b and c, NF-κB activation in GC-A -/-mice was elevated to the same level as GC-A +/+ mice after 2 days of reperfusion. Although the precise reason for the absence of difference in NF-κB activation after 2 days of reperfusion was not clear, one possible explanation is that there are many other mechanisms involved in NF-κB activation in the late phase of ischemia/reperfusion. In 2 days of reperfusion, NF-κB might be activated by other cytokines, for example, TNF-α. Our unpublished observations suggest that TNF-α mRNA level peaks at 2-3 days after myocardial infarction in mice. We found previously that GC-A-deficient mice, which are derived from the C57BL/6 and SVJ 129 strains, are hypertensive and exhibit marked ventricular hypertrophy (26) . Even though these mice were backcrossed with C57BL/6 mice for at least five generations and comparisons were made among littermates, it was still possible that the observed differences in infarct size might have been due to differences in the hemodynamics or genetic backgrounds of the mice. To rule out that possibility, we blocked endogenous GC-A pharmacologically using HS at a dosage that did not affect systemic blood pressure (data not shown). Pretreatment with HS reduced myocardial infarct size and coronary endothelial P-selectin expression, confirming the role played by endogenous GC-A during myocardial ischemia/reperfusion in wild-type mice.
To further investigate whether ANP directly affects Pselectin expression, we examined P-selectin expression in cultured HUVECs, where GC-A is abundantly expressed. Treating the cells with ANP increased both cell surface expression ( Figure 6e ) and total expression of P-selectin protein (Figure 6f ). Because ischemia/ reperfusion injury is known to correlate with oxidative stress, we exposed HUVECs to H 2 O 2 and found that it, too, increased cell surface (Figure 6e ) and total ( Figure  6f ) expression of P-selectin, while combined exposure to ANP and H 2 O 2 yielded even larger increases, which were blocked by pretreatment with HS.
It is very important to examine how ANP or BNP activates NF-κB since little is known regarding cross-talk between the natriuretic peptide pathway and the NF-κB pathway. However, Kalra et al. recently reported that cyclic GMP-dependent kinase directly interacts with and phosphorylates IκBα, which leads to the activation of NF-κB in feline cardiomyocytes (54) . Considering the findings, we examined phosphorylation and degradation of IκBα in ANP/H 2 O 2 -treated HUVECs. Incubation of HUVEC with ANP for 1 hour alone did not either phosphorylate IκBα or activate NF-κB. ANP further augmented H 2 O 2 -induced phosphorylation and NF-κB activation. Incubation of cells with H 2 O 2 alone did not affect degradation of IκBα. ANP in the presence of H 2 O 2 also did not affect IκBα degradation. These data agree well with the previous report (45) . These results provide the evidence that ANP modulates NF-κB activation in the presence of oxidative stress through IκBα phosphorylation without degradation.
As the synthesis and secretion of BNP are markedly augmented after acute myocardial infarction (22) , it is likely that endogenous natriuretic peptides upregulate Pselectin expression during ischemia/reperfusion. Although, to our knowledge, there have been no reports on the effect of natriuretic peptides on the expression of endothelial adhesion molecules, Steven et al. (55) showed P-selectin expression to be upregulated and infarct size to be larger in eNOS-deficient mice. It is intriguing to us that GC-A-and eNOS-knockout mice show opposite tendencies with respect to P-selectin expression, even though both natriuretic peptides and NO transduce their signals by elevating the level of cGMP. The reason for this discrepancy is currently unknown, and it would be interesting to examine the NO pathway in GC-A -/-mice.
In the present study, it is indicated that the increase in natriuretic peptide levels might play an important role in regulating inflammatory responses after cardiac ischemia reperfusion. Furthermore, our finding that GC-A inhibition during the acute phase has a beneficial effect on myocardial reperfusion injury raises the possibility of future clinical application. However, we must clarify the effect of suppressing inflammatory response in the infarct area on healing processes and the effect of remodeling during the chronic phase in noninfarct lesions. Therefore, additional study will be necessary to determine the clinical applicability of GC-A inhibition and the most appropriate timing and extent to which GC-A should be inhibited during acute myocardial ischemia and reperfusion.
At present, ANP has been used clinically to treat patients with acute heart failure, including patients with AMI who have undergone acute reperfusion therapy. When ANP is infused to patients at a rate of 0.1 µg/kg/min, the plasma concentration of ANP reached approximately 3 ng/ml (1 nM). In contrast, the ventricular concentration of ANP in the normal ventricle is about 17.5 ng/g (56) , which corresponds to about 6 nM, and could be increased after ischemia/reperfusion, as is the case in mice (Table 1) . Thus, ventricular ANP concentration is several times higher than plasma concentration, even in ANP-treated patients. Therefore, it is unlikely that ANP infusion augments to a greater extent cardiac P-selectin expression or PMN infiltration. On the other hand, ANP infusion improves preload and afterload through diuretic, natriuretic, and vasodilating activities of ANP. Further studies are necessary to evaluate whether ANP infusion before or just after reperfusion of coronary artery in AMI is useful or harmful.
In conclusion, inhibition of the natriuretic peptide pathway suppresses NF-κB-mediated inflammatory processes during acute myocardial ischemia/reperfusion, and, as a result, reduces myocardial infarct size. The present study provides a new insight into the role of natriuretic peptide/GC-A pathway in myocardial ischemia/reperfusion.
